SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (761)3/5/1998 11:26:00 AM
From: maileg  Read Replies (1) of 1826
 
which would make Richard Bagnell's question about the recent paper on MGI-114's mode of action somewhat prescient:

Ahah! Exactly what I was thinking! David, did the person your friend spoke with at MGI state specifically the leukemia comment, or was that his interpretation, based on this paper Richard had quoted?

When I read Richard's post, I also wondered whether leukemia would soon enter the clinical picture...

Thanks David, that's great news. NCI is very slow; it's good they're taking their own road, too.

Darci
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News